Viewing Study NCT00004260


Ignite Creation Date: 2025-12-25 @ 2:16 AM
Ignite Modification Date: 2026-01-06 @ 11:21 PM
Study NCT ID: NCT00004260
Status: COMPLETED
Last Update Posted: 2011-08-03
First Post: 2000-01-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Interleukin-12 Plus Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
Sponsor: Mayo Clinic
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module